Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2017 1
2018 4
2019 4
2020 7
2021 4
2022 2
2023 4
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical Trial.
Renard E, Weinstock RS, Aleppo G, Bode BW, Brown SA, Castorino K, Hirsch IB, Kipnes MS, Laffel LM, Lal RA, Penfornis A, Riveline JP, Shah VN, Thivolet C, Ly TT; OP5-003 Research Group. Renard E, et al. Diabetes Care. 2024 Dec 1;47(12):2248-2257. doi: 10.2337/dc24-1550. Diabetes Care. 2024. PMID: 39423118 Free PMC article. Clinical Trial.
ACBP/DBI neutralization for the experimental treatment of fatty liver disease.
Motiño O, Lambertucci F, Joseph A, Durand S, Anagnostopoulos G, Li S, Carbonnier V, Nogueira-Recalde U, Montégut L, Chen H, Aprahamian F, Nirmalathasan N, Maiuri MC, Pietrocola F, Valla D, Laouénan C, Gautier JF, Castera L; QUID NASH Investigators; Martins I, Kroemer G. Motiño O, et al. Cell Death Differ. 2025 Mar;32(3):434-446. doi: 10.1038/s41418-024-01410-6. Epub 2024 Nov 16. Cell Death Differ. 2025. PMID: 39550516 Free PMC article.
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes.
Castera L, Garteiser P, Laouenan C, Vidal-Trécan T, Vallet-Pichard A, Manchon P, Paradis V, Czernichow S, Roulot D, Larger E, Pol S, Bedossa P, Correas JM, Valla D, Gautier JF, Van Beers BE; QUID NASH investigators. Castera L, et al. Among authors: vidal trecan t. J Hepatol. 2024 Aug;81(2):195-206. doi: 10.1016/j.jhep.2024.03.023. Epub 2024 Mar 27. J Hepatol. 2024. PMID: 38548067
Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes.
Julla JB, Girard D, Diedisheim M, Saulnier PJ, Tran Vuong B, Blériot C, Carcarino E, De Keizer J, Orliaguet L, Nemazanyy I, Potier C, Khider K, Tonui DC, Ejlalmanesh T, Ballaire R, Mambu Mambueni H, Germain S, Gaborit B, Vidal-Trécan T, Riveline JP, Garchon HJ, Fenaille F, Lemoine S, Carlier A, Castelli F, Potier L, Masson D, Roussel R, Vandiedonck C, Hadjadj S, Alzaid F, Gautier JF, Venteclef N. Julla JB, et al. Among authors: vidal trecan t. Circ Res. 2024 Jan 19;134(2):189-202. doi: 10.1161/CIRCRESAHA.123.322757. Epub 2023 Dec 28. Circ Res. 2024. PMID: 38152893 Free article.
The concept of immunothrombosis in pancreas transplantation.
Masset C, Drillaud N, Ternisien C, Degauque N, Gerard N, Bruneau S, Branchereau J, Blancho G, Mesnard B, Brouard S, Giral M, Cantarovich D, Dantal J; TREPID Group. Masset C, et al. Am J Transplant. 2025 Apr;25(4):650-668. doi: 10.1016/j.ajt.2024.11.025. Epub 2024 Dec 19. Am J Transplant. 2025. PMID: 39709128 Review.
Effectiveness of Six International Guidelines Using Fibrosis-4 and FibroScan for Risk Stratification of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes.
Vidal-Trécan T, Julla JB, El Khoury T, Venteclef N, Riveline JP, Paradis V, Valla D, Gautier JF, Castera L. Vidal-Trécan T, et al. Clin Gastroenterol Hepatol. 2025 Nov;23(12):2176-2186.e2. doi: 10.1016/j.cgh.2025.02.018. Epub 2025 May 8. Clin Gastroenterol Hepatol. 2025. PMID: 40348110
[Renal artery fibromuscular dysplasia].
Amar L, Azarine A, Carreira E, Vidal-Trécan T, Plouin PF. Amar L, et al. Among authors: vidal trecan t. Presse Med. 2011 Jul-Aug;40(7-8):720-5. doi: 10.1016/j.lpm.2011.02.033. Epub 2011 Apr 16. Presse Med. 2011. PMID: 21498033 French.
Autoimmune diabetes induced by PD-1 inhibitor-retrospective analysis and pathogenesis: a case report and literature review.
Gauci ML, Laly P, Vidal-Trecan T, Baroudjian B, Gottlieb J, Madjlessi-Ezra N, Da Meda L, Madelaine-Chambrin I, Bagot M, Basset-Seguin N, Pages C, Mourah S, Boudou P, Lebbé C, Gautier JF. Gauci ML, et al. Among authors: vidal trecan t. Cancer Immunol Immunother. 2017 Nov;66(11):1399-1410. doi: 10.1007/s00262-017-2033-8. Epub 2017 Jun 20. Cancer Immunol Immunother. 2017. PMID: 28634815 Free PMC article. Review.
Acquired generalized lipodystrophy under immune checkpoint inhibition.
Haddad N, Vidal-Trecan T, Baroudjian B, Zagdanski AM, Arangalage D, Battistella M, Gautier JF, Lebbe C, Delyon J; PATIO group. Haddad N, et al. Among authors: vidal trecan t. Br J Dermatol. 2020 Feb;182(2):477-480. doi: 10.1111/bjd.18124. Epub 2019 Aug 9. Br J Dermatol. 2020. PMID: 31077337
Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), Société francaise d'endocrinologie (SFE), Société francophone de transplantation (SFT) and Société française de néphrologie - dialyse - transplantation (SFNDT).
Wojtusciszyn A, Branchereau J, Esposito L, Badet L, Buron F, Chetboun M, Kessler L, Morelon E, Berney T, Pattou F, Benhamou PY, Vantyghem MC; TREPID group. Wojtusciszyn A, et al. Diabetes Metab. 2019 Jun;45(3):224-237. doi: 10.1016/j.diabet.2018.07.006. Epub 2018 Sep 14. Diabetes Metab. 2019. PMID: 30223084 Review.
29 results